Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Persistent phenothiazine dyskinesia treated with tetrabenazine.

Literature DB >> 4938245

Persistent phenothiazine dyskinesia treated with tetrabenazine.

Abstract

Six patients with persistent phenothiazine dyskinesia were treated in a double-blind controlled trial with tetrabenazine 100 mg in divided dosage. In three patients the abnormal movements were abolished and in two others there was some improvement, but this was no greater than that achieved with the diazepam control. Tetrabenazine may be useful in the treatment of some patients with persistent phenothiazine dyskinesia.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1971 PMID： 4938245 PMCID： PMC1799203 DOI： 10.1136/bmj.4.5778.25

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

3 in total

1. AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION.

Authors: R HUNTER; C J EARL; S THRONICROFT
Journal: Proc R Soc Med Date: 1964-08

2. [Neurological complications of neuroleptic medication].

Authors: J SIGWALD; D BOUTTIER; S COURVOISIER
Journal: Rev Neurol (Paris) Date: 1959-06 Impact factor: 2.607

3. Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia.

Authors: K Pind; A Faurbye
Journal: Acta Psychiatr Scand Date: 1970 Impact factor: 6.392

3 in total

9 in total

Persistent phenothiazine dyskinesia treated with tetrabenazine.

1. AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION.

2. [Neurological complications of neuroleptic medication].

3. Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid after treatment with probenecid in patients with drug-induced tardive dyskinesia.

1. Tardive Dyskinesia.

Review 2. Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Review 3. Management of tardive dyskinesia: current update.

4. Benzodiazepines in psychotic States.

5. Tetrabenazine (Nitoman) therapy of chronic spontaneous oral dyskinesia. A video- and EMG-controlled study.

Review 6. VMAT2 Inhibitors in Neuropsychiatric Disorders.

Review 7. Tetrabenazine: Spotlight on Drug Review.

Review 8. Benzodiazepines for antipsychotic-induced tardive dyskinesia.

Review 9. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.